Performance of qualitative and quantitative antigen tests for SARS-CoV-2 in early symptomatic patients using saliva
View ORCID ProfileIsao Yokota, Takayo Sakurazawa, View ORCID ProfileJunichi Sugita, Sumio Iwasaki, Keiko Yasuda, Naoki Yamashita, Shinichi Fujisawa, View ORCID ProfileMutsumi Nishida, View ORCID ProfileSatoshi Konno, View ORCID ProfileTakanori Teshima
doi: https://doi.org/10.1101/2020.11.06.20227363
Isao Yokota
1Department of Biostatistics, Hokkaido University Faculty of Medicine, Sapporo, Japan
PhD, MPHTakayo Sakurazawa
2Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan
Junichi Sugita
2Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan
MD, PhDSumio Iwasaki
2Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan
BSKeiko Yasuda
2Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan
BSNaoki Yamashita
2Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan
BSShinichi Fujisawa
2Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan
BSMutsumi Nishida
2Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan
PhDSatoshi Konno
3Department of Respiratory Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan
Takanori Teshima
2Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan
4Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan
MD, PhD
Posted November 10, 2020.
Performance of qualitative and quantitative antigen tests for SARS-CoV-2 in early symptomatic patients using saliva
Isao Yokota, Takayo Sakurazawa, Junichi Sugita, Sumio Iwasaki, Keiko Yasuda, Naoki Yamashita, Shinichi Fujisawa, Mutsumi Nishida, Satoshi Konno, Takanori Teshima
medRxiv 2020.11.06.20227363; doi: https://doi.org/10.1101/2020.11.06.20227363
Performance of qualitative and quantitative antigen tests for SARS-CoV-2 in early symptomatic patients using saliva
Isao Yokota, Takayo Sakurazawa, Junichi Sugita, Sumio Iwasaki, Keiko Yasuda, Naoki Yamashita, Shinichi Fujisawa, Mutsumi Nishida, Satoshi Konno, Takanori Teshima
medRxiv 2020.11.06.20227363; doi: https://doi.org/10.1101/2020.11.06.20227363
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (718)
- Anesthesia (210)
- Cardiovascular Medicine (3002)
- Dermatology (256)
- Emergency Medicine (449)
- Epidemiology (12900)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4698)
- Geriatric Medicine (432)
- Health Economics (742)
- Health Informatics (2986)
- Health Policy (1081)
- Hematology (399)
- HIV/AIDS (942)
- Medical Education (439)
- Medical Ethics (116)
- Nephrology (481)
- Neurology (4486)
- Nursing (239)
- Nutrition (657)
- Oncology (2329)
- Ophthalmology (659)
- Orthopedics (262)
- Otolaryngology (330)
- Pain Medicine (290)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1218)
- Primary Care Research (509)
- Public and Global Health (7073)
- Radiology and Imaging (1570)
- Respiratory Medicine (933)
- Rheumatology (454)
- Sports Medicine (390)
- Surgery (497)
- Toxicology (62)
- Transplantation (214)
- Urology (187)